Purchase Order 75N92B19P00040
- Not listed
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) to Otogenetics Corporation, a minority-owned, small disadvantaged, woman-owned business. The $15,999 firm fixed-price purchase order was for next-generation sequencing laboratory services, including whole exome sequencing, clinical genetic testing, and data analysis to support NIH research programs. Otogenetics has been awarded multiple federal...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Otogenetics Corporation, a minority-owned, small disadvantaged business, for laboratory supplies and other functions. The contract has a ceiling value of $80,000.00 and a period of performance that ends on April 1, 2016. Otogenetics Corporation is a next-generation sequencing laboratory service provider that specializes in services such as whole exome...
- The U.S. government awarded a $24,997 purchase order to Otogenetics Corporation for RNA sequencing (RNA SEQ) services. This firm fixed-price contract was executed on April 26, 2016, with a completion date of May 6, 2016, and was performed at the company's facility in Dunwoody, Georgia. The contract was funded by a civilian federal agency within the Southeast Area and was not designated as a set-aside for any specific business category. Otogenetics Corporation is a next-generation sequencing...
- Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order contract valued at $24,350 by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for laboratory testing services to support genomic sequencing and bioinformatics research efforts. Specifically, Novogene will provide DNA/RNA sample sequencing and data analysis services leveraging Illumina and PacBio platforms, including whole...
- Novogene Corp Inc., a minority-owned small business, has been awarded a $13,982 firm fixed price purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide RNA sequencing services in Bethesda, Maryland. The sequencing will support the agency's biomedical research efforts. As a prime contractor supporting multiple federal agencies, Novogene has over 100 contracts to conduct genomic sequencing and analysis for studies into diseases,...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $24,577.00 firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for DNA and RNA sequencing services. This contract is set aside for small businesses. Novogene is a provider of next-generation sequencing technologies that has delivered services to support various federal agencies' biomedical, agricultural, environmental, and basic...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The $11,766 contract is for sequencing and analysis services to be provided by Novogene Corp Inc., a minority-owned small business. The services include next-generation sequencing of DNA and RNA samples, library preparation, and associated bioinformatics analysis. This contract is not designated as...
- This is a $13,400 firm fixed-price purchase order contract awarded by the National Eye Institute, a civilian agency within the National Institutes of Health, to Novogene Corp Inc., a minority-owned small business. The contract is for cell handling and sequencing services, with a period of performance through September 30, 2024. Novogene is a genomics services provider that specializes in next-generation DNA and RNA sequencing, bioinformatics, and research support for federal agencies across...
- The Department of Health and Human Services' National Institutes of Health National Institute on Deafness and Other Communication Disorders awarded a $24,950.00 firm fixed price purchase order to Novogene Corp Inc., a minority-owned small business, for processing mouse tissue to create a next-generation sequencing (NGS) mouse library. The contract has an August 25, 2025 completion date and was awarded on August 26, 2022. Novogene is an experienced provider of genomic sequencing and...
- This is a firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization specializing in genetic testing and analysis services. The contract, valued at $147,260.00, is for the provision of genotyping services for rodent samples to support the NIAMS intramural research program. The contract does not have a...
Otogenetics Corporation, a minority-owned, small disadvantaged business, has been awarded a $24,849 firm-fixed-price purchase order contract by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases. The contract, which is not set aside for any specific business category, is for the provision of next-generation sequencing laboratory services, including whole exome sequencing, clinical genetic testing, and data analysis, to support research programs related to arthritis, musculoskeletal disorders, and skin diseases. Otogenetics also holds a larger $100 million Blanket Purchase Agreement with the NIH for specialized laboratory testing, sequencing, and analysis services to support the agency's biomedical research mission.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Close Out | ($25k) | 4/5/24 | |
| P00001 | Other Administrative Action | $0 | 8/3/22 | |
| Not listed | Not listed | $24.8k | 8/19/19 |